So my friend, Justin Morgenstern recently put up a post on Idarucizumab, aka Praxbind. He seemed pretty fired up on the issue, so I got him on the line to talk about it. What follows is a conversation on evidence and what to do when there is not a good amount of it.
Justin Wrote an Additional Post after our Discussion
On to the Wee…
Latest posts by Scott Weingart (see all)
- EMCrit 233 – EMCrit Failed Airway Algorithm 2018 from ResusTO - September 19, 2018
- EMCrit 232 – SteelMan Debate – EMS Field Decisions in Cardiac Arrest with Howie Mell - September 5, 2018
- EMCrit 231 – How to Practice Cricothyroidotomy (Cric) - August 25, 2018